Deferred Revenue (Tables)

12 Months Ended

Jul. 31, 2017

Deferred Revenue Disclosure [Abstract]

The following is a summary of the Company’s deferred revenue activity for the fiscal years ended July 31, 2017 and 2016:

	OORT		BED		Other Opioid Treatments		Total
Balance as of July 31, 2015	$	4,300,000	$	1,000,000	$	-	$	5,300,000
Recognized as revenue		(4,800,000)		-		-		(4,800,000)
Investment from Potomac		500,000		-		-		500,000
Investment from the Foundation				-		1,600,000		1,600,000
Balance as of July 31, 2016		-		1,000,000		1,600,000		2,600,000
Recognized as revenue		-		(39,854)		-		(39,854)
Balance as of July 31, 2017	$	-	$	960,146	$	1,600,000	$	2,560,146

Schedule of Deferred Revenue, by Arrangement

As of July 31, 2017, the Company had recorded $253,619 of its deferred revenue as a current liability because the Company expects to recognize that amount as revenue during the next twelve (12) months. The remaining $2,306,527 was recorded as a long-term liability as of July 31, 2017, as detailed in the following table:

	OORT		BED		Other Opioid Treatments		Total
Current portion	$	-	$	253,619	$	-	$	253,619
Long-term portion		-		706,527		1,600,000		2,306,527
Total	$	-	$	960,146	$	1,600,000	$	2,560,146